President Trump's executive order on expanding access to in vitro fertilization (IVF) services will have several implications for Yale University. Primarily, it will affect Yale's employee health benefits plans, which will need review and potential adjustment to ensure compliance with any new federal mandates regarding fertility treatment coverage.

Yale School of Medicine and Yale New Haven Hospital will experience operational impacts through potentially increased demand for fertility services and possible changes to clinical practice guidelines. The order may present expanded opportunities for reproductive medicine research and education programs, possibly increasing both costs and revenues in these areas.

Administratively, Yale will need to coordinate benefits compliance across its system, update relevant policies, and ensure proper implementation of any new federal guidelines. While this will increase administrative burden, it also presents opportunities for Yale to strengthen its position in reproductive medicine and related research fields.